BCM
Bayesian Capital Management’s Quest Diagnostics DGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82M | Buy |
+15,700
| New | +$2.82M | 0.45% | 56 |
|
|
2025
Q1 | – | Sell |
-11,800
| Closed | -$1.78M | – | 688 |
|
|
2024
Q4 | $1.78M | Buy |
+11,800
| New | +$1.78M | 0.22% | 141 |
|
|
2024
Q3 | – | Sell |
-8,800
| Closed | -$1.2M | – | 760 |
|
|
2024
Q2 | $1.2M | Buy |
+8,800
| New | +$1.2M | 0.14% | 198 |
|
|
2023
Q1 | – | Sell |
-7,600
| Closed | -$1.19M | – | 865 |
|
|
2022
Q4 | $1.19M | Buy |
7,600
+5,163
| +212% | +$808K | 0.17% | 146 |
|
|
2022
Q3 | $299K | Sell |
2,437
-434
| -15% | -$53.2K | 0.06% | 413 |
|
|
2022
Q2 | $382K | Buy |
+2,871
| New | +$382K | 0.07% | 401 |
|
|
2021
Q4 | – | Sell |
-1,600
| Closed | -$232K | – | 414 |
|
|
2021
Q3 | $232K | Buy |
+1,600
| New | +$232K | 0.07% | 319 |
|
|
2020
Q4 | – | Sell |
-13,463
| Closed | -$1.54M | – | 502 |
|
|
2020
Q3 | $1.54M | Buy |
13,463
+10,163
| +308% | +$1.16M | 0.38% | 63 |
|
|
2020
Q2 | $376K | Buy |
+3,300
| New | +$376K | 0.08% | 303 |
|
|
2020
Q1 | – | Sell |
-8,900
| Closed | -$950K | – | 814 |
|
|
2019
Q4 | $950K | Buy |
8,900
+2,200
| +33% | +$235K | 0.16% | 186 |
|
|
2019
Q3 | $717K | Buy |
+6,700
| New | +$717K | 0.14% | 210 |
|
|
2017
Q3 | – | Sell |
-2,900
| Closed | -$322K | – | 519 |
|
|
2017
Q2 | $322K | Buy |
+2,900
| New | +$322K | 0.12% | 274 |
|